Progress in the Development of Bestatin Analogues as Aminopeptidases Inhibitors

Current Medicinal Chemistry

Volumn 18, Issue 7, 2011, Pages 964-976

  Chen, L ^a   Teng, Y ^a   Xu, W ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Aminopeptidases; Analogues; Bestatin; Optimization

Indexed keywords

1 METHYL CYCLOHEXAN BESTATIN; AMINOPEPTIDASE; AMINOPEPTIDASE B; AMINOPEPTIDASE P; APSTATIN; AROMATIC COMPOUND; BESTATIN; BESTATIN DERIVATIVE; CARBOXYL GROUP; CYTOSOL AMINOPEPTIDASE; ENZYME INHIBITOR; METHIONYL AMINOPEPTIDASE; METHYL BESTATIN; MICROSOMAL AMINOPEPTIDASE; PEPTOID; PHOSPHORUS DERIVATIVE; TERT BUTYL BESTATIN; THIOAMIDE; THIOBESTATIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CHIRALITY; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; NONHUMAN; PROCESS OPTIMIZATION; PROTEIN SYNTHESIS INHIBITION; STRUCTURE ANALYSIS;

AMINOPEPTIDASES; ANIMALS; ENZYME INHIBITORS; HUMANS; LEUCINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79952803469     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711794940879     Document Type: Article

References (64)

1. Taylor, A. Aminopeptidases: Structure and function. FASEB. J., 1993, 7(2), 290-298. (Pubitemid 23067779)
2. Drag, M.; Bogyo, M.; Ellman, J.A.; Salvesen, G.S. Aminopeptidase fingerprints, an integrated approach for identification of good substrates and optimal inhibitors. J. Biol. Chem., 2010, 285(5), 3310-3318.
3. Bachmair, A.; Finley, D.; Varshavsky, A. In vivo half-life of a protein is a function of its amino-terminal residue. Science, 1986, 234(4733), 179-186. (Pubitemid 17186094)
4. Stragier, B.; De Bundel, D.; Sarre, S.; Smolders, I.; Vauquelin, G.; Dupont, A.; Michotte, Y.; Vanderheyden, P. Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: A review. Heart. Fail. Rev., 2008, 13(3), 321-337.
5. Chai, S.Y.; Yeatman, H.R.; Parker, M.W.; Ascher, D.B.; Thompson, P.E.; Mulvey, H.T.; Albiston, A.L. Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase. BMC Neurosci., 2008, 9 Suppl 2, S14.
6. Bodineau, L.; Frugiere, A.; Marc, Y.; Inguimbert, N.; Fassot, C.; Balavoine, F.; Roques, B.; Llorens-Cortes, C. Orally active aminopeptidase A inhibitors reduce blood pressure - a new strategy for treating hypertension. Hypertension, 2008, 51(5), 1318-1325. (Pubitemid 351555944)
7. Bank, U.; Bohr, U.R.; Reinhold, D.; Lendeckel, U.; Ansorge, S.; Malfertheiner, P.; Tager, M. Inflammatory bowel diseases: Multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors. Front. Biosci., 2008, 13, 3699-3713. (Pubitemid 351594653)
8. Hui, K.S. Brain-specific aminopeptidase: From enkephalinase to protector against neurodegeneration. Neurochem. Res., 2007, 32(12), 2062-2071.
9. Taylor, A. Aminopeptidases: Towards a mechanism of action. Trends Biochem. Sci., 1993, 18(5), 167-171.
10. Hopsu-Havu, V.K.; Makinen, K.K.; Glenner, G.G. Formation of Bradykinin from Kallidin-10 by Aminopeptidase B. Nature, 1966, 212, 1271-1272.
11. Pham, V.L.; Cadel, M.S.; Gouzy-Darmon, C.; Hanquez, C.; Beinfeld, M.C.; Nicolas, P.; Etchebest, C.; Foulon, T. Aminopeptidase B, a glucagonprocessing enzyme: Site directed mutagenesis of the Zn2+-binding motif and molecular modelling. BMC Biochem., 2007, 8, 21.
12. Zhang, X.P.; Xu, W.F. Aminopeptidase N (APN/CD13) as a target for anticancer agent design. Curr. Med. Chem., 2008, 15(27), 2850-2865.
13. Saiki, I.; Yoneda, J.; Azuma, I.; Fujii, H.; Abe, F.; Nakajima, M.; Tsuruo, T. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer, 1993, 54(1), 137-143. (Pubitemid 23137011)
14. Yaron, A.; Naider, F. Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol., 1993, 28(1), 31-81. (Pubitemid 23065603)
15. Mizutani, S.; Shibata, K.; Kikkawa, F.; Hattori, A.; Tsujimoto, M.; Ishii, M.; Kobayashi, H. Essential role of placental leucine aminopeptidase in gynecologic malignancy. Expert. Opin. Ther. Targets, 2007, 11(4), 453-461. (Pubitemid 46487594)
16. Umezawa, H. Screening of small molecular microbial products modulating immune responses and bestatin. Recent Results Cancer Res., 1980, 75, 115-125.
17. Taylor, A.; Surgenor, T.; Thomson, D.K.; Graham, R.J.; Oettgen, H. Comparison of leucine aminopeptidase from human lens, beef lens and kidney, and hog lens and kidney. Exp. Eye Res., 1984, 38(3), 217-229. (Pubitemid 14148150)
18. Scott, C.S.; Davey, M.; Hamilton, A.; Norfolk, D.R. Serum enzyme concentrations in untreated acute myeloid leukaemia. Blut, 1986, 52(5), 297-303. (Pubitemid 16117362)
19. Selvakumar, P.; Lakshmikuttyamma, A.; Dimmock, J.R.; Sharma, R.K. Methionine aminopeptidase 2 and cancer. Biochim. Biophys. Acta, 2006, 1765(2), 148-154.
20. Gordon, E.M.; Godfrey, J.D.; Delaney, N.G.; Asaad, M.M.; Von Langen, D.; Cushman, D.W. Design of novel inhibitors of aminopeptidases. Synthesis of peptide-derived diamino thiols and sulfur replacement analogues of bestatin. J. Med. Chem., 1988, 31(11), 2199-2211.
21. Bogra, P.; Singh, J.; Singh, H., Purification and characterization of aminopeptidase B from goat brain. Process. Biochem., 2009, 44(7), 776-780.
22. Sanz, Y.; Toldrá, F. Purification and characterization of an arginine aminopeptidase from Lactobacillus sakei. Appl. Environ. Microbiol., 2002, 68, 1980-1987. (Pubitemid 34280010)
23. Zhang, J.; Li, X.; Zhu, H.W.; Wang, Q.; Feng, J.H.; Mou, J.J.; Li, Y.G.; Fang, H.; Xu, W.F. Design, synthesis, and primary activity evaluation of pyrrolidine derivatives as matrix metalloproteinase inhibitors. Drug Discov. Ther., 2010, 4(1), 5-12.
24. Inagaki, Y.; Tang, W.; Zhang, L.; Du, G.H.; Xu, W.F.; Kokudo, N. Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis. BioSci. Trends, 2010, 4(2), 56-60.
25. Zhu, H.W.; Fang, H.; Wang, L.Y.; Hu, W.X.; Xu, W.F. 3D-QSAR study with pharmacophore-based molecular alignment of hydroxamic acid-related phosphinates that are aminopeptidase N inhibitors. Drug Discov. Ther., 2008, 2(1), 52-57.
26. Sweeney, P.J.; Walker, J.M. Aminopeptidase M (EC 3.4.11.2), pyroglutamate aminopeptidase (EC 3.4.19.3), and prolidase (EC 3.4.13.9). Methods Mol. Biol., 1993, 16, 319-329.
27. Stoeckel-Maschek, A.; Stiebitz, B.; Koelsch, R.; Neubert, K. Novel 3-amino- 2-hydroxy acids containing protease inhibitors. Synthesis and kinetic characterization as aminopeptidase P inhibitors. Bioorg. Med. Chem., 2005, 13(16), 4806-4820. (Pubitemid 40943505)
28. Molinaro, G.; Carmona, A.K.; Juliano, M.A.; Juliano, L.; Malitskaya, E.; Yessine, M.A.; Chagnon, M.; Lepage, Y.; Simmons, W.H.; Boileau, G.; Adam, A. Human recombinant membrane-bound aminopeptidase P: Production of a soluble form and characterization using novel, internally quenched fluorescent substrates. Biochem. J., 2005, 385(Pt 2), 389-397. (Pubitemid 40165071)
29. Schu, P. Aminopeptidase I enzymatic activity. Methods Enzymol., 2008, 451, 67-78.
30. Grembecka, J.; Mucha, A.; Cierpicki, T.; Kafarski, P. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity. J. Med. Chem., 2003, 46(13), 2641-2655. (Pubitemid 36702533)
31. Jackson, R.; Hunter, T. Role of methionine in the initiation of haemoglobin synthesis. Nature, 1970, 227(5259), 672-676.
32. Umezawa, H.; Aoyagi, T.; Suda, H.; Hamada, M.; Takeuchi, T. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J. Antibiot., 1976, 29( 1 ), 97-99.
33. Talmadge, J.E.; Lenz, B.F.; Pennington, R.; Long, C.; Phillips, H.; Schneider, M.; Tribble, H. Immunomodulatory and therapeutic properties of bestatin in mice. Cancer Res., 1986, 46, 4505-4510. (Pubitemid 16046879)
34. Aozuka, Y.; Koizumi, K.; Saitoh, Y.; Ueda, Y.; Sakurai, H.; Saiki, I. Antitumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16- BL6 melanoma cells orthotopically implanted into syngeneic mice. Cancer Lett., 2004, 216(1), 35-42. (Pubitemid 39410494)
35. Ocain, T.D.; Rich, D.H. alpha-Keto amide inhibitors of aminopeptidases. J. Med. Chem., 1992, 35(3), 451-456.
36. Wilkes, S.H.; Prescott, J.M. The slow, tight binding of bestatin and amastatin to aminopeptidases. J. Biol. Chem., 1985, 260(24), 13154-13162. (Pubitemid 16209789)
37. Rich, D.H.; Moon, B.J.; Harbeson, S. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slowbinding processes. J. Med. Chem., 1984, 27(4), 417-422. (Pubitemid 14133727)
38. Ricci, J.S.; Bousvaros, A.; Taylor, A. The crystal and molecular structure of bestatin and its implications regarding substrate binding to the active site of leucine aminopeptidase. J. Org. Chem., 1982, 47(16), 3063-3065.
39. Nishizawa, R.; Saino, T.; Takita, T.; Suda, H.; Aoyagi, T. Synthesis and structure-activity relationships of bestatin analogues, inhibitors of aminopeptidase B. J. Med. Chem., 1977, 20(4), 510-515. (Pubitemid 8065704)
40. Herranz, R.; Vinuesa, S.; Perez, C.; Garcia-Lopez, M.T.; Lopez, E.; de Ceballos, M.L.; Del Rio, J. Analgesic dipeptide derivatives. 7. 3,7-Diamino- 2-hydroxyheptanoic acid (DAHHA) containing dipeptide analogues of the analgesic compound H-Lys-Trp(Nps)-OMe. J. Med. Chem., 1992, 35(5), 889-895.
41. Sendzik, M.; Janc, J.W.; Cabuslay, R.; Honigberg, L.; Mackman, R.L.; Magill, C.; Squires, N.; Waldeck, N. Design and synthesis of beta-aminoalpha- hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth. Bioorg. Med. Chem. Lett., 2004, 14(12), 3181-3184. (Pubitemid 38624589)
42. Stamper, C.C.; Bienvenue, D.L.; Bennett, B.; Ringe, D.; Petsko, G.A.; Holz, R.C. Spectroscopic and X-ray crystallographic characterization of bestatin bound to the aminopeptidase from Aeromonas (Vibrio) proteolytica. Biochemistry, 2004, 43(30), 9620-9628. (Pubitemid 38993812)
43. Burley, S.K.; David, P.R.; Sweet, R.M.; Taylor, A.; Lipscomb, W.N. Structure determination and refinement of bovine lens leucine aminopeptidase and its complex with bestatin. J. Mol. Biol., 1992, 224(1), 113-140.
44. Ocain, T.D.; Rich, D.H. Synthesis of sulfur-containing analogs of bestatin. Inhibition of aminopeptidases by alpha-thiolbestatin analogues. J. Med. Chem., 1988, 31(11), 2193-2199.
45. Fournie-Zaluski, M.C.; Coric, P.; Turcaud, S.; Bruetschy, L.; Lucas, E.; Noble, F.; Roques, B.P. Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation. J. Med. Chem., 1992, 35(7), 1259-1266.
46. Herranz, R.; Castro-Pichel, J.; Garcia-Lopez, M.T.; Gomez-Monterrey, I.; Perez, C.; Vinuesa, S. Ketomethylenebestatin: Synthesis and aminopeptidase inhibition. Arch. Pharm. (Weinheim), 1993, 326(7), 395-398. (Pubitemid 23242086)
47. Harbeson, S.L.; Rich, D.H. Inhibition of aminopeptidases by peptides containing ketomethylene and hydroxyethylene amide bond replacements. J. Med. Chem., 1989, 32(6), 1378-1392. (Pubitemid 19149998)
48. Yang, K.; Wang, Q.; Su, L.; Fang, H.; Wang, X.; Gong, J.; Wang, B.; Xu, W. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors. Bioorg. Med. Chem., 2009, 17(11), 3810-3817.
49. Bartlett, P.A.; Kezer, W.B. Phosphinic acid dipeptide analogs: Potent, slowbinding inhibitors of aspartic peptidases. J. Am. Chem. Soc., 1984, 106(15), 4282-4283.
50. Giannousis, P.P.; Bartlett, P.A. Phosphorus amino acid analogues as inhibitors of leucine aminopeptidase. J. Med. Chem., 1987, 30(9), 1603-1609 (Pubitemid 17135907)
51. Chen, H.; Noble, F.; Roques, B.P.; Fournie-Zaluski, M.C. Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugs. J. Med. Chem., 2001, 44(21), 3523-3530. (Pubitemid 32947917)
52. Chen, H.; Noble, F.; Coric, P.; Fournie-Zaluski, M.-C.; Roques, B.P. Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: A class of central analgesics. Proc. Natl. Acad. Sci. U.S.A., 1998, 95(20), 12028-12033.
53. Skinner-Adams, T.S.; Lowther, J.; Teuscher, F.; Stack, C.M.; Grembecka, J.; Mucha, A.; Kafarski, P.; Trenholme, K.R.; Dalton, J.P.; Gardiner, D.L. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds. J. Med. Chem., 2007, 50(24), 6024-6031.
54. Chung, M.C.; lee, H.J.; Chun, H.K.; Lee, C.H.; Kim, S.I.; Kho, Y.H. Bestatin analogues from streptomyces neyagawaensis SL-387. Biosci. Biotech. Biochem., 1996, 60(5), 898-900.
55. Nagai, M.; Kojima, F.; Naganawa, H.; Hamada, M.; Aoyagi, T.; Takeuchi, T. Phebestin, a new inhibitor of aminopeptidase N, produced by Streptomyces sp. MJ716-m3. J. Antibiot (Tokyo), 1997, 50(1), 82-84. (Pubitemid 27078063)
56. Chung, M.C.; Chun, H.K.; Han, K.H.; Lee, H.J.; Lee, C.H.; Kho, Y.H. R- 387A and B, new aminopeptidase N inhibitors, produced by Streptomyces neyagawaensis SL-387. J. Antibiot., 1996, 49(1), 99-102.
57. Yoshida, S.; Nakamura, Y.; Naganawa, H.; Aoyagi, T.; Takeuchi, T. Probestin, a new inhibitor of aminopeptidase M, produced by Streptomyces azureus MH663-2F6. II. Structure determination of probestin. J. Antibiot (Tokyo)., 1990, 43(2), 149-153. (Pubitemid 20069962)
58. Aoyagi, T.; Yoshida, S.; Nakamura, Y.; Shigihara, Y.; Hamada, M.; Takeuchi, T. Probestin, a new inhibitor of aminopeptidase M, produced by Streptomyces azureus MH663-2F6. I. Taxonomy, production, isolation, physicochemical properties and biological activities. J. Antibiot (Tokyo),. 1990, 43(2), 143-148. (Pubitemid 20069961)
59. Ma, T.; Xu, W.; Wang, J.; Yuan, Y. Design, synthesis and anti-cancer activity of AHPA derivatives. Chin. J. Med. Chem. , 2003, 13(2), 70-75.
60. Maggiora, L.L.; Orawski, A.T.; Simmons, W.H. Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme. J. Med. Chem., 1999, 42(13), 2394-2402. (Pubitemid 29305173)
61. Luan, Y.P.; Wang, X.J.; Zhu, H.W.; Qu, X.J.; Fang, H.; Xu, W.F. The synthesis and activity evaluation of a Bestatin derivative (LYP) as an aminopeptidase N inhibitor. Lett. Drug Des. Discov., 2009, 6(6), 420-423.
62. Saitoh, Y.; Koizumi, K.; Minami, T.; Sekine, K.; Sakurai, H.; Saiki, I. A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells. Biol. Pharm. Bull., 2006, 29(4), 709-712.
63. Luan, Y.; Xu, W. The structure and main functions of aminopeptidase N. Curr. Med. Chem., 2007, 14(6), 639-647. (Pubitemid 46477717)
64. Xu, W.; Li, Q. Progress in the development of aminopeptidase N (APN/CD13) inhibitors. Curr. Med. Chem., 2005, 5(3), 281-301. (Pubitemid 40645595)